Asston Pharmaceuticals Completes Key Leadership Appointments in Board Meeting
Published on: March 30, 2026, 11:38 p.m. | Source: scanx.trade
Asston Pharmaceuticals Limited successfully concluded its board meeting on March 30, 2026, implementing significant leadership changes including the appointment of Mr. Sumit Pawar as CFO, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director. The company also approved an Extraordinary General Meeting for April 28, 2026, demonstrating strong corporate governance and regulatory compliance.
